T. Rowe Price Associates Inc. MD Increases Stake in Glaukos Co.

Summary

T. Rowe Price Associates Inc. MD increased its stake in Glaukos Co. (NYSE: GKOS) by 13.7%, buying an additional 4,227 shares, bringing the total holdings to 35,182 shares valued at $5.28 million. Other institutional investors like William Blair and AllianceBernstein also made significant purchases. Analysts have mixed ratings for GKOS, with a consensus target price of $137.62. The stock opened at $87.60, with a range over the past year from $77.10 to $163.71. Glaukos reported quarterly earnings per share of ($0.22), exceeding expectations.Market Beat

Impact Analysis

This is a company-level event reflecting institutional investors’ increased confidence in Glaukos Co., despite mixed analyst ratings and recent negative earnings per share. The action by T. Rowe Price Associates Inc. MD, along with other investors like William Blair and AllianceBernstein, suggests potential for positive stock performance or strategic developments. First-order effects include immediate market reactions potentially boosting the stock price, aligning with the consensus target price of $137.62, which is well above the current opening price of $87.60. Second-order effects may involve increased attention from other investors and potential strategic maneuvers by Glaukos Co. Investment opportunities might include purchasing shares of GKOS anticipating a price increase towards the target, though risks involve the company’s ability to overcome current earnings deficits and market volatility.Market Beat